期刊文献+

血清25羟基维生素D水平与多囊卵巢综合征的关联研究 被引量:10

The correlation analysis of serum 25 hydroxyvitamin D levels and Polycystic ovarian syndrome
原文传递
导出
摘要 目的:探讨血清25羟基维生素D〔25(OH)VD〕水平与多囊卵巢综合征(PCOS)发病的关联性。方法:采用病例-对照研究分析非肥胖研究对象133例,其中PCOS 72例、非PCOS对照61例。通过问卷调查和自动化平台检测收集研究对象的基本特征,同时检测血清钙和25(OH)VD水平,并将相关指标进行相关性分析。结果:PCOS患者血清25(OH)VD水平显著低于对照组,血清25(OH)VD水平与体质指数、空腹胰岛素、睾酮和胰岛素抵抗都呈明显负相关,与雌二醇呈明显正相关(P<0.05)。结论:血清25(OH)VD水平可作为监测PCOS病理进程的重要标记物,并在PCOS的预防和临床治疗方面具备潜在的应用价值。 Objective: To explore the relationship between serum 25 hydroxyvitamin D levels and Polycystic ovarian syndrome (PCOS) in our country. Methods: A case - control study including a total of 133 non - obese subjects (72 PCOS individuals and 61 healthy controls) was used in this study. Basic characteristics were collected by questionnaire and standardized anthropometric measurements. Serum Ca and 25 hydroxyvitamin D concentrations were detected and related indicators were used for correlation analysis. Results: (~Serum 25 hydroxyvitamin D levels were significantly decreased in patients with PCOS compared with controls ( P 〈 0. 05 ) . (2~Serum 25 hydroxyvitamin D concentrations were significantly correlated with body mass index (BMI), fasting insulin, insulin resistance, testosterone and estradiol. Conclusion: Serum 25 hydroxyvitamin D levels may be the important biomarkers of monitoring the pathogenesis of PCOS, and have potential applications in the prevention and clinical treatment of PCOS.
出处 《中国妇幼保健》 CAS 北大核心 2013年第8期1333-1335,共3页 Maternal and Child Health Care of China
基金 国家自然科学基金资助项目〔No.81170619〕
关键词 多囊卵巢综合征 25羟基维生素D 相关性研究 Polycystic ovarian syndrome 25 hydroxyvitamin D Correlation analysis
  • 相关文献

参考文献8

  • 1Boucher B J, John WG, Noonan K. Hypovitaminosis D is asso- ciated with insulin resistance and beta cell dysfunction [J] . Am J Clin Nutr, 2004, 80 (6) : 1666.
  • 2Zella JB, Me Cary LC, DeLuca HF. Oral administration of 1, 25- dihydroxyvitamin D3 completely protects NOD mice from insulin -dependent diabetes mellitus [J] . Arch Biochem Bio- phys, 2003, 417 (1): 77.
  • 3Kotsa K, Yavropoulou MP, Anastasiou O et al. Role of vita- min D treatment in glucose metabolism in polycystic ovary syn- drome [J] . Fertil Steril, 2009, 92 (3): 1053.
  • 4Glintborg D, Andersen M. An update on the pathogenesis, in- flammation, and metabolism in hirsutism and polycystic ovary syndrome [J] . Gynecol Endocrinol, 2010, 26 (4): 281.
  • 5Panidis D, Balaris C, Farmakiotis D et al. Serum parathyroid hormone concentrations are increased in women with polycystic ovary syndrome [J] . Clin Chem, 2005, 51 (9) : 1691.
  • 6Welsh P, Peters MJ, Sattar N. Vitamin D insufficiency [J]. N Engl J Med, 2011, 364 (14) : 1378.
  • 7Muscogiuri G, Policola C, Prioletta A et al. Low levels of 25 (OH) D and insulin -resistance: 2 unrelated features or a cause -effect in PCOS? [J] . Clin Nutr, 2012, 31 (4) : 476.
  • 8Sathyapalan T, Shepherd J, Arnett C et al. Atorvastatin in- creases 25 -hydroxyvitamin D concentrations in patients with polycystic ovary syndrome [ J ] . Clin Chem, 2010, 56 (11): 1696.

同被引文献75

引证文献10

二级引证文献59

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部